FDA Sentinel Initiative & Pharmacovigilance 2020

Danijela Stojanovic and Monica Muñoz from CDER’s Office of Surveillance and Epidemiology (OSE) provide an overview of FDA’s Sentinel Initiative, to include the Active Post-market Risk Identification and Analysis System (ARIA) and its application. They also describe the approach towards building signal identification capabilities in Sentinel.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2020 Playlist: https://www.youtube.com/playlist?list=PLey4Qe-UxcxZiTopt4biuIyxmUQJDkaWb
LinkedIn: https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
Training resources: https://www.fda.gov/cderbsbialearn

Twitter: https://twitter.com/FDA_Drug_Info

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionmanagement

Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367